Hepatitis - AASLD - Liver Conference - HCV - HepC - HBV - HepB
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hepatitis E-newsletter
Join Us:
HIGHLIGHTS
What you need to know
> Blogs > Hep Exclusives > Hepatitis News > Lessons


Hepatitis C Surpasses HIV as Cause of Death in U.S.

It’s official. Chronic hepatitis C virus infection is associated with more deaths than HIV infection.



100% Hep C Genotype 2/3 Cure

Promising results for interferon-free PSI-7977 regimen.



Targeting
Hep C

Gene-targeting therapy shows promise against hepatitis C.


The Liver Meeting 2011

Latest from the American Association For the Study of Liver Diseases (AASLD).



Combo Shines In Treating HCV

24-week experimental combo cured 91 percent of people with genotype 1 hep C.



HIV/HCV Treatment Options Coming

Incivek and Victrelis working well in coinfection studies.


Baby Boomers and Hep C

Testing individuals born between 1945 and 1965 would help identify more than 800,000 people living with hep C.



Combo Hep B Treatment Shows Limited Benefit

Baraclude/Viread generally no better than Baraclude alone.



Hep C Pipeline Update From AASLD

Join the conversation in the Hep Forums.

NEWSFEED
AASLD Coverage

Hep C Protease Inhibitors May Not Be Cost-Effective For Some First-Time Treatment Takers

BMS Oral Hep C Drug Combo Cures 90% of Null Responders With Genotype 1b in Japanese Study

Blood Thinner Reduces Liver Vein Blood Clots, Protects Liver Functioning in People With Cirrhosis

Interferon-Free Protease/Polymerase Inhibitor Combo Showing Well in Hep C Genotype 1 Study

Milk Thistle Extract Comparable to Placebo in Hep C Liver Enzyme Study

Interferon-Free Alisporivir Treatment Showing Promise in Genotype 2/3 Trial

TMC435, Peg-Interferon and Ribavirin Combo Boosts Cure Rates for Hep C Genotype 1

Five-Year Viread Follow-Up: Long-Term Hep B Suppression, Plus Fibrosis and Cirrhosis Improvements

Hepatitis C Surpasses HIV as Cause of Death in U.S.

Testing All Baby Boomers for Hep C Would Find 86% of Infections, Say Researchers

Incivek, Victrelis Working Well in HIV/HCV Coinfection Studies

Gene-Targeting Therapy Shows Promise Against Hepatitis C

PSI-7977, Peg-Interferon, Ribavirin Combo Shines in Genotype 1 Hep C Study

Adding Viread to Baraclude for Hep B Treatment Shows Limited Benefit

Twelve Weeks Interferon-Free PSI-7977 Regimen Cures 100 Percent Hep C Genotype 2/3

HEP TV
Footage from the front lines
This video by Dr. Joseph Galati outlines the basic facts about hepatitis C, and a call to action to get tested and evaluated for treatment. Learn more about Dr. Galati at www.texasliver.com.
> More Hep TV
TALK TO US
Tell us what you think
Poll
Do you know any young people (under age 30) who are currently living with hepatitis C?
Yes
No


Survey
Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.